The Icahn School of Medicine at Mount Sinai has launched the AI Small Molecule Drug Discovery Center, a bold endeavor that harnesses artificial intelligence (AI) to revolutionize drug development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback